Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	53.32	-133.67	-286.39
Graham Fair Price	41.42	2.82	2.00
PEG	4.95	-0.02	0.02
Price/Book	-12.73	0.27	0.31
Price/Cash Flow	12.73	-18.43	-21.12
Prices/Earnings	56.36	-2.42	-5.54
Price/Sales	-56.36	1.59	3.63
Price/FCF	12.73	-18.43	-21.12
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-14.21	0.06	0.07
Operating Margin	0.00	-0.04	-0.04
ROA	-100.00	-0.02	< 0.005
ROE	-0.01	-0.03	-100.00
ROIC	< 0.005	< 0.005	-91.83
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	< 0.005	0.11	-99.06
Dividends QOQ	1.00	< 0.005	-100.00
EBIT QOQ	0.56	-1.00	77.15
EPS QOQ	-2.41	-1.00	58.42
FCF QOQ	0.24	0.00	inf
Revenue QOQ	-0.50	1.00	98.03
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	284.54	140.72	-50.54
Days Sales Outstanding (DSO)	85.45	43.12	-49.53
Inventory Turnover	0.32	0.64	102.19
Debt/Capitalization	0.30	0.30	0.07
Quick Ratio	0.30	0.30	-0.23
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	3.57	3.57	< 0.005
Cash	0.32	0.32	-1.26
Capex	< 0.005	< 0.005	< 0.005
Free Cash Flow	-0.05	-0.05	< 0.005
Revenue	0.30	0.61	100.00
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.79	0.79	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-151.95	-75.47	50.33
Naive Interpretation	Member

06 - Financial Health · Bad

Rating